Nephrocare Health Services vs Nifty 50: Returns Compared

Nephrocare Health Services vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Nephrocare Health Services trades on the NSE under the symbol NEPHROPLUS, and its 1-month return of -14.52% compares with -5.12% for the Nifty 50 over the same period.

The Nephrocare Health Services vs Nifty 50 comparison matters because Nephrocare Health Services is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Nephrocare Health Services share price performance against the Nifty 50 across 1 month, 3 months and 6 months, using NSE closing data up to 8 October 2026. NSE price history for Nephrocare Health Services begins on 17 December 2025, so the table covers only the time frames with a full trading record.

Also read – Neuland Laboratories vs Nifty 50: Returns Compared

Click Here – Get Free Investment Predictions

Nephrocare Health Services vs Nifty 50: Performance at a Glance

The table below sets out the Nephrocare Health Services vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 8 October 2026.

Time Frame	Nephrocare Health Services Return	Nifty 50 Return	Difference
1 Month	-14.52%	-5.12%	-9.40 pp
3 Months	-1.02%	-7.22%	+6.20 pp
6 Months	+13.52%	-6.49%	+20.01 pp

On the Nephrocare Health Services vs Nifty 50 scorecard, Nephrocare Health Services has beaten the index over the latest 6-month window, returning +13.52% against -6.49% for the Nifty 50, a difference of 20.01 percentage points. That is also the widest gap anywhere in the table. The direction differs over the past six months: Nephrocare Health Services moved up while the Nifty 50 moved down.

Check the Univest Screener for live Nephrocare Health Services and Nifty 50 data

Latest Close and 52-Week Range: Nephrocare Health Services and the Nifty 50

Instrument	Latest Close	52-Week High	52-Week Low	Vs 52-Week High
Nephrocare Health Services	Rs 626.95	Rs 781.50	Rs 446.00	-19.8%
Nifty 50	22,231.80	26,373.20	22,179.90	-15.7%

Nephrocare Health Services closed at Rs 626.95 on 8 October 2026, which is 19.8% below its 52-week high of Rs 781.50 and 40.6% above its 52-week low of Rs 446.00. The Nifty 50 closed at 22,231.80, 15.7% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Nephrocare Health Services vs Nifty 50 Gap Exists

Nephrocare Health Services can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Nephrocare Health Services has traded between Rs 446.00 and Rs 781.50, a spread of 75.2% from low to high, against 18.9% for the Nifty 50.

Trading depth also shapes the Nephrocare Health Services vs Nifty 50 gap. Stocks with a smaller trading base tend to react more to a single result, block deal or news item than the diversified Nifty 50 does, and Nephrocare Health Services is judged on its own record rather than on an average.

Download the Univest iOS App or Univest Android App to track Nephrocare Health Services and Nifty 50 live on the go.

Nephrocare Health Services vs Nifty 50: Has Nephrocare Health Services Beaten the Benchmark?

Yes, over the past six months. Nephrocare Health Services returned +13.52% against -6.49% for the Nifty 50, a lead of 20.01 percentage points. Across the three time frames measured, Nephrocare Health Services is ahead of the index over 3 months and 6 months and behind it over 1 month.

Risks of the Nephrocare Health Services vs Nifty 50 Comparison

Reading too much into a Nephrocare Health Services vs Nifty 50 comparison has real limitations. Point-to-point returns depend entirely on the start date chosen, so a stock that looks ahead of the index over one window can look behind over the next, and none of these figures predicts future returns.

Also read – New Delhi Television vs Nifty 50: Returns Compared

Nephrocare Health Services carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 446.00 to Rs 781.50 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Nephrocare Health Services vs Nifty 50 shows Nephrocare Health Services ahead of the index in 2 of 3 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit Nephrocare Health Services into a wider portfolio.

Has Nephrocare Health Services outperformed the Nifty 50 in the last 6 months?

Ans. Yes. Nephrocare Health Services returned +13.52% over the past six months while the Nifty 50 returned -6.49%, based on NSE closing prices to 8 October 2026.

How does Nephrocare Health Services vs Nifty 50 look over the last month?

Ans. Over the past month Nephrocare Health Services has returned -14.52% compared with the Nifty 50's -5.12%, so in the Nephrocare Health Services vs Nifty 50 comparison the stock has been behind over this horizon.

What is the Nephrocare Health Services share price today compared to Nifty 50?

Ans. Nephrocare Health Services share price closed at Rs 626.95 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.

What is the 52-week high and low of Nephrocare Health Services?

Ans. Nephrocare Health Services's 52-week high is Rs 781.50 and its 52-week low is Rs 446.00, based on NSE data. The latest close of Rs 626.95 is 19.8% below the high.

Why does Nephrocare Health Services show bigger price swings than the Nifty 50?

Ans. Nephrocare Health Services carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Nephrocare Health Services has traded in a 75.2% low-to-high range against 18.9% for the index, a key reason the Nephrocare Health Services vs Nifty 50 return gap varies across time frames.

Is Nephrocare Health Services a good long-term investment compared to a Nifty 50 index fund?

Ans. Nephrocare Health Services's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Nephrocare Health Services vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.